NO951966D0 - - Google Patents

Info

Publication number
NO951966D0
NO951966D0 NO951966A NO951966A NO951966D0 NO 951966 D0 NO951966 D0 NO 951966D0 NO 951966 A NO951966 A NO 951966A NO 951966 A NO951966 A NO 951966A NO 951966 D0 NO951966 D0 NO 951966D0
Authority
NO
Norway
Application number
NO951966A
Other languages
Norwegian (no)
Other versions
NO951966L (en:Method
Inventor
Elisabeth B Fraser-Smith
Anthony C Allison
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1992/009932 external-priority patent/WO1994012184A1/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO951966D0 publication Critical patent/NO951966D0/no
Publication of NO951966L publication Critical patent/NO951966L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO951966A 1992-11-24 1995-05-18 NO951966L (en:Method)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98083892A 1992-11-24 1992-11-24
PCT/US1992/009932 WO1994012184A1 (en) 1992-11-24 1992-11-24 Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
CA002144189A CA2144189A1 (en) 1992-11-24 1992-11-24 Prevention of stenosis

Publications (2)

Publication Number Publication Date
NO951966D0 true NO951966D0 (en:Method) 1995-05-18
NO951966L NO951966L (en:Method) 1995-05-18

Family

ID=27169974

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951966A NO951966L (en:Method) 1992-11-24 1995-05-18

Country Status (2)

Country Link
CA (1) CA2144189A1 (en:Method)
NO (1) NO951966L (en:Method)

Also Published As

Publication number Publication date
CA2144189A1 (en) 1994-06-09
NO951966L (en:Method) 1995-05-18

Similar Documents

Publication Publication Date Title
BR9304651A (en:Method)
BR9202713C1 (en:Method)
DE9207553U1 (en:Method)
NO951966D0 (en:Method)
BRPI9204323A2 (en:Method)
BR9304980A (en:Method)
AU1803592A (en:Method)
AU634140B1 (en:Method)
AU1610792A (en:Method)
AU1622092A (en:Method)
AU1708392A (en:Method)
AU1729392A (en:Method)
AU1081792A (en:Method)
AU1812892A (en:Method)
AU1842892A (en:Method)
AU1861992A (en:Method)
AU1862992A (en:Method)
AU1866292A (en:Method)
AU1933792A (en:Method)
AU1935292A (en:Method)
AU2054092A (en:Method)
AU2281492A (en:Method)
AU2527392A (en:Method)
AU2620092A (en:Method)
AU2629492A (en:Method)